{"id":"https://openalex.org/W4406233315","doi":"https://doi.org/10.5415/apallergy.0000000000000162","title":"Predictors of treatment control in severe chronic urticaria treated with omalizumab","display_name":"Predictors of treatment control in severe chronic urticaria treated with omalizumab","publication_year":2025,"publication_date":"2025-01-08","ids":{"openalex":"https://openalex.org/W4406233315","doi":"https://doi.org/10.5415/apallergy.0000000000000162","pmid":"https://pubmed.ncbi.nlm.nih.gov/40933429","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12419318"},"language":"en","primary_location":{"id":"doi:10.5415/apallergy.0000000000000162","doi":"https://doi.org/10.5415/apallergy.0000000000000162","is_oa":true,"landing_page_url":"https://doi.org/10.5415/apallergy.0000000000000162","pdf_url":null,"source":{"id":"https://openalex.org/S2737535774","display_name":"Asia Pacific Allergy","issn_l":"2233-8276","issn":["2233-8276","2233-8268"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asia Pacific Allergy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.5415/apallergy.0000000000000162","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006860059","display_name":"Miguel Proen\u00e7a","orcid":"https://orcid.org/0000-0002-5526-7533","observed_orcids":["https://orcid.org/0000-0002-5526-7533"]},"institutions":[{"id":"https://openalex.org/I4405258248","display_name":"Unidade Local de Sa\u00fade da Arr\u00e1bida","ror":"https://ror.org/00bz9sk84","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405258248"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Miguel Proen\u00e7a","raw_affiliation_strings":["Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal","institution_ids":["https://openalex.org/I4405258248"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022204604","display_name":"Jo\u00e3o Lu\u00eds Alves Marcelino","orcid":"https://orcid.org/0000-0001-8462-8847","observed_orcids":["https://orcid.org/0000-0001-8462-8847"]},"institutions":[{"id":"https://openalex.org/I4405258248","display_name":"Unidade Local de Sa\u00fade da Arr\u00e1bida","ror":"https://ror.org/00bz9sk84","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405258248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","PT"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Marcelino","raw_affiliation_strings":["Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Germany","Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal"],"raw_orcid":"https://orcid.org/0000-0001-8462-8847","affiliations":[{"raw_affiliation_string":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]},{"raw_affiliation_string":"Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal","institution_ids":["https://openalex.org/I4405258248"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085256207","display_name":"Jo\u00e3o Victor Pruner Vieira","orcid":"https://orcid.org/0000-0003-3539-249X","observed_orcids":["https://orcid.org/0000-0003-3539-249X"]},"institutions":[{"id":"https://openalex.org/I4405258248","display_name":"Unidade Local de Sa\u00fade da Arr\u00e1bida","ror":"https://ror.org/00bz9sk84","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405258248"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Vieira","raw_affiliation_strings":["Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal","institution_ids":["https://openalex.org/I4405258248"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138706005","display_name":"Joana Guimar\u00e3es","orcid":"https://orcid.org/0009-0008-7128-7332","observed_orcids":["https://orcid.org/0009-0008-7128-7332"]},"institutions":[{"id":"https://openalex.org/I4405258248","display_name":"Unidade Local de Sa\u00fade da Arr\u00e1bida","ror":"https://ror.org/00bz9sk84","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405258248"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Joana Guimar\u00e3es","raw_affiliation_strings":["Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal"],"raw_orcid":"https://orcid.org/0009-0008-7128-7332","affiliations":[{"raw_affiliation_string":"Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal","institution_ids":["https://openalex.org/I4405258248"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Carlota Dias","orcid":"https://orcid.org/0009-0007-7890-5757","observed_orcids":["https://orcid.org/0009-0007-7890-5757"]},"institutions":[{"id":"https://openalex.org/I4405258248","display_name":"Unidade Local de Sa\u00fade da Arr\u00e1bida","ror":"https://ror.org/00bz9sk84","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405258248"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Carlota Dias","raw_affiliation_strings":["Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal"],"raw_orcid":"https://orcid.org/0009-0007-7890-5757","affiliations":[{"raw_affiliation_string":"Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal","institution_ids":["https://openalex.org/I4405258248"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009024979","display_name":"Elza Tom\u00e1z","orcid":"https://orcid.org/0000-0001-8880-9629","observed_orcids":["https://orcid.org/0000-0001-8880-9629"]},"institutions":[{"id":"https://openalex.org/I4405258248","display_name":"Unidade Local de Sa\u00fade da Arr\u00e1bida","ror":"https://ror.org/00bz9sk84","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4405258248"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Elza Tomaz","raw_affiliation_strings":["Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal"],"raw_orcid":"https://orcid.org/0000-0001-8880-9629","affiliations":[{"raw_affiliation_string":"Immunology and Allergy Department, Unidade Local de Sa\u00fade Arr\u00e1bida, Portugal","institution_ids":["https://openalex.org/I4405258248"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5006860059"],"corresponding_institution_ids":["https://openalex.org/I4405258248"],"apc_list":null,"apc_paid":null,"fwci":3.894,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.92204057,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"15","issue":"3","first_page":"159","last_page":"165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10634","display_name":"Food Allergy and Anaphylaxis Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":1.0},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7379999756813049},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.9549999833106995},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.6629999876022339},{"id":"https://openalex.org/keywords/anti-thyroid-peroxidase-antibodies","display_name":"thyroid peroxidase antibodies","score":0.8050000071525574},{"id":"https://openalex.org/keywords/anti-dsdna-antibodies","display_name":"anti-dsDNA antibodies","score":0.9179999828338623},{"id":"https://openalex.org/keywords/total-serum-ige","display_name":"total IgE","score":0.8199999928474426},{"id":"https://openalex.org/keywords/anti-iga-antibodies","display_name":"anti-IgA antibodies","score":0.621999979019165},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9910463094711304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9817055463790894},{"id":"https://openalex.org/C3017745231","wikidata":"https://www.wikidata.org/wiki/Q187440","display_name":"Chronic urticaria","level":2,"score":0.7474817037582397},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5912879705429077},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.2135622799396515},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14803794026374817},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.14112946391105652}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.5415/apallergy.0000000000000162","doi":"https://doi.org/10.5415/apallergy.0000000000000162","is_oa":true,"landing_page_url":"https://doi.org/10.5415/apallergy.0000000000000162","pdf_url":null,"source":{"id":"https://openalex.org/S2737535774","display_name":"Asia Pacific Allergy","issn_l":"2233-8276","issn":["2233-8276","2233-8268"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asia Pacific Allergy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12419318","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12419318/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12419318/pdf/pa9-15-159.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asia Pac Allergy","raw_type":"Text"},{"id":"pmid:40933429","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40933429","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asia Pacific allergy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.5415/apallergy.0000000000000162","doi":"https://doi.org/10.5415/apallergy.0000000000000162","is_oa":true,"landing_page_url":"https://doi.org/10.5415/apallergy.0000000000000162","pdf_url":null,"source":{"id":"https://openalex.org/S2737535774","display_name":"Asia Pacific Allergy","issn_l":"2233-8276","issn":["2233-8276","2233-8268"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asia Pacific Allergy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4406233315.pdf","grobid_xml":"https://content.openalex.org/works/W4406233315.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1527171042","https://openalex.org/W2002479630","https://openalex.org/W2030696258","https://openalex.org/W2037982270","https://openalex.org/W2048435726","https://openalex.org/W2087190080","https://openalex.org/W2165654773","https://openalex.org/W2216732451","https://openalex.org/W2736673906","https://openalex.org/W2763782620","https://openalex.org/W2767225949","https://openalex.org/W2789266588","https://openalex.org/W2793609975","https://openalex.org/W2810953097","https://openalex.org/W2825786282","https://openalex.org/W2887855058","https://openalex.org/W2888422117","https://openalex.org/W2891642619","https://openalex.org/W2943438248","https://openalex.org/W2951200598","https://openalex.org/W2970454426","https://openalex.org/W3002816942","https://openalex.org/W3012389903","https://openalex.org/W3087522660","https://openalex.org/W3100643583","https://openalex.org/W3126817223","https://openalex.org/W3158901631","https://openalex.org/W3170638465","https://openalex.org/W3189791963","https://openalex.org/W3200862524","https://openalex.org/W4211160325","https://openalex.org/W4220775599","https://openalex.org/W4229032466","https://openalex.org/W4229056048","https://openalex.org/W4308318524","https://openalex.org/W4389275835"],"related_works":["https://openalex.org/W4391751353","https://openalex.org/W2962081186","https://openalex.org/W4391535187","https://openalex.org/W4411880798","https://openalex.org/W4391535094","https://openalex.org/W4362589091","https://openalex.org/W7023597219","https://openalex.org/W4414927194","https://openalex.org/W4415737359","https://openalex.org/W7169985547"],"abstract_inverted_index":{"Background:":[0],"Real-life":[1],"clinical":[2,155,203,224,244],"research":[3],"on":[4,75],"biomarkers":[5,30],"that":[6,31,257],"predict":[7,32],"therapy":[8,19],"outcomes":[9],"of":[10,44,99,116,135,287,298],"severe":[11,47],"chronic":[12,48,78],"spontaneous":[13,79],"urticaria":[14,49,80],"patients":[15,45,81,83,101,119,259],"receiving":[16],"omalizumab":[17],"(OMA)":[18],"is":[20,273],"still":[21],"limited.":[22],"For":[23],"this":[24],"reason,":[25],"we":[26],"aimed":[27],"to":[28,35,56,91,94,143,171,267,289],"identify":[29],"the":[33,132,172,195],"response":[34,93,156,204,225,245],"OMA":[36,52,265,290],"treatment.":[37],"Methods:":[38],"A":[39],"single-center,":[40],"observational,":[41],"retrospective":[42],"review":[43],"with":[46,51,221,241,264,276],"treated":[50],"from":[53],"January":[54,57],"2015":[55],"2023":[58],"in":[59,292],"a":[60,127,140,153,158,176,191,201,222,242,277,306],"Portuguese":[61],"Immunology":[62],"and":[63,68,131,152,200,305],"Allergy":[64],"Department.":[65],"One-way":[66],"ANOVA":[67],"linear":[69],"regression":[70],"were":[71,218],"used.":[72],"Results:":[73],"Data":[74],"56":[76],"OMA-treated":[77],"shows":[82],"can":[84],"be":[85],"divided":[86],"into":[87],"3":[88],"groups":[89],"according":[90],"their":[92,105],"OMA.":[95],"The":[96,113,165],"first":[97],"group":[98,115,134,148,213,234],"26":[100],"(46.4%)":[102],"successfully":[103],"reduced":[104],"IMA":[106],"dose":[107,129,142,177,283],"without":[108],"experiencing":[109],"any":[110],"rebound":[111],"effects.":[112],"second":[114],"19":[117],"(33.9%)":[118],"achieved":[120],"disease":[121,145],"control":[122],"but":[123,270],"could":[124],"not":[125],"tolerate":[126],"progressive":[128],"reduction,":[130],"third":[133],"11":[136],"(19.6%)":[137],"patients,":[138],"required":[139],"higher":[141,261,307],"achieve":[144],"control.":[146],"In":[147,212,233],"1,":[149],"patient":[150],"age":[151,167,272],"favorable":[154,202,223,243],"had":[157],"positive":[159,302],"correlation":[160,193],"(":[161,181,205,226,246],"P":[162,185,209,230,250],"=":[163,183,186,207,210,228,231,248,251],"0.008).":[164],"patient\u2019s":[166],"was":[168,179,189,238],"also":[169,190,274],"correlated":[170,220,240],"time":[173],"interval":[174,279],"until":[175],"reduction":[178],"tolerated":[180],"r":[182,206,227,247],"0.69;":[184],"0.005).":[187],"There":[188],"negative":[192],"between":[194],"ratio:":[196],"thyroid":[197,215],"peroxidase":[198,216,300],"antibodies/total-IgE":[199],"\u22120.74;":[208],"0.021).":[211],"2,":[214],"antibodies":[217],"negatively":[219,239],"\u22120.55;":[229],"0.027).":[232],"3,":[235],"anti-double-stranded":[236],"DNA":[237],"\u22120,97;":[249],"0,007).":[252],"Conclusion:":[253],"Our":[254],"study":[255],"suggests":[256],"older":[258],"experience":[260],"success":[262],"rates":[263],"compared":[266],"younger":[268],"individuals,":[269],"increasing":[271],"associated":[275],"longer":[278],"before":[280],"achieving":[281],"successful":[282],"reduction.":[284],"Potential":[285],"markers":[286],"resistance":[288],"identified":[291],"our":[293],"cohort":[294],"included":[295],"elevated":[296],"levels":[297],"IgG-antithyroid":[299,308],"antibodies,":[301,304],"anti-dsDNA":[303],"peroxidase/total-IgE":[309],"ratio.":[310]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-01-10T00:00:00"}